Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Overall Study	STARTED	PF-04531083 1000 mg	22
Overall Study	STARTED	PF-04531083 2000 mg	23
Overall Study	STARTED	Ibuprofen 400 mg	22
Overall Study	STARTED	Placebo	23
Overall Study	COMPLETED	PF-04531083 1000 mg	20
Overall Study	COMPLETED	PF-04531083 2000 mg	23
Overall Study	COMPLETED	Ibuprofen 400 mg	22
Overall Study	COMPLETED	Placebo	22
Overall Study	NOT COMPLETED	PF-04531083 1000 mg	2
Overall Study	NOT COMPLETED	PF-04531083 2000 mg	0
Overall Study	NOT COMPLETED	Ibuprofen 400 mg	0
Overall Study	NOT COMPLETED	Placebo	1

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01512160/flow